P. Bardet

Junctional adhesion molecule-A is dispensable for myeloid cell recruitment and diversification in the tumor microenvironment

C. Goyvaerts, J. V. Van Ginderachter, A. Talebi, 2022, Frontiers in Immunology.

Macrophages are metabolically heterogeneous within the tumor microenvironment.

Y. Saeys, R. De Rycke, C. Gysemans, 2020, Cell reports.

IL1β Promotes Immune Suppression in the Tumor Microenvironment Independent of the Inflammasome and Gasdermin D

D. Lambrechts, L. Boon, M. Mazzone, 2020, Cancer Immunology Research.

Therapeutic depletion of CCR8+ tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy

F. Tacke, L. Boon, B. Neyns, 2021, Journal for ImmunoTherapy of Cancer.

Unleashing Tumour-Dendritic Cells to Fight Cancer by Tackling Their Three A’s: Abundance, Activation and Antigen-Delivery

D. Laoui, Aleksandar Murgaski, Pauline Bardet, 2019, Cancers.

Innate Immune Defense Mechanisms by Myeloid Cells That Hamper Cancer Immunotherapy

J. V. Van Ginderachter, M. Kiss, G. Raes, 2020, Frontiers in Immunology.

Macrophages are metabolically heterogeneous within the tumor microenvironment.

Y. Saeys, R. De Rycke, C. Gysemans, 2021, Cell reports.

Flt3L therapy increases the abundance of Treg-promoting CCR7+ cDCs in preclinical cancer models

J. V. Van Ginderachter, Emile Clappaert, Y. Elkrim, 2023, Frontiers in immunology.